Find comprehensive information on documenting and coding the diagnosis of Presence of Watchman Device. This guide covers relevant healthcare, clinical documentation, and medical coding terms including LAA closure, left atrial appendage occlusion, Watchman implant, ICD-10 code for Watchman device, and CPT code for Watchman procedure. Learn about proper medical record documentation for patients with a Watchman device and ensure accurate coding for reimbursement.
Also known as
Presence of foreign body
Codes for presence of various internal prosthetic devices and implants.
Heart failure
Watchman is used in patients with non-valvular atrial fibrillation with risk of stroke.
Atrial fibrillation and flutter
The Watchman device is specifically designed for patients with this condition.
Follow this step-by-step guide to choose the correct ICD-10 code.
Is the Watchman device currently in place and functioning?
Yes
Any complications?
No
Was it removed?
When to use each related code
| Description |
|---|
| Watchman Device Present |
| LAA Occlusion, Non-Watchman |
| No LAA Occlusion Device |
Coding lacks specificity, failing to capture the exact Watchman model (e.g., FLX, LAAC). Impacts data accuracy and reimbursement.
Documentation ambiguity leads to incorrect coding for device placement or removal. Causes claims errors and compliance issues.
Failure to code device-related complications (e.g., perforation, thrombosis) understates patient acuity and resource utilization.
Patient presents for routine follow-up with a history of left atrial appendage closure using the Watchman device. The procedure was performed on [Date of Procedure] due to non-valvular atrial fibrillation and a CHADS2-VASc score of [Score] indicating a high risk of stroke. Patient is currently asymptomatic and tolerating anticoagulation well, although prior to Watchman implantation, the patient experienced [Reason for discontinuation of oral anticoagulation - e.g., gastrointestinal bleeding or intolerance]. Physical examination is unremarkable with stable vital signs. Transesophageal echocardiogram (TEE) performed on [Date of TEE] confirms stable position of the Watchman device within the left atrial appendage with no evidence of peridevice leak, thrombus formation, or device embolization. Left ventricular ejection fraction (LVEF) is estimated at [LVEF Percentage]. Current medications include [List Medications]. Patient reports compliance with medication regimen. Plan is to continue current medications and schedule follow-up TEE in [Timeframe - e.g., 6 months or 1 year] to monitor device function and rule out complications. Patient education provided regarding signs and symptoms of potential complications, including device migration, thrombosis, and pericardial effusion. Patient understands the importance of ongoing monitoring and follow-up.